Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Behavioural symptoms and capacity in dementia

Neurology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Sudden agitation, drowsiness, hallucinations or refusal of care needs urgent assessment for delirium, pain, infection, retention, constipation, medicine toxicity, hypoxia and metabolic illness. Immediate serious harm may require proportionate emergency action, but dementia alone never authorises restraint, covert medication or treatment without a capacity and legal framework.

Synopsis

Formulate distress and behaviour in dementia through unmet need and delirium assessment, use antipsychotics only within strict risk criteria, and apply decision-specific Mental Capacity Act practice.

  • Describe the behaviour precisely—who, when, where, trigger, duration and consequence—rather than using 'challenging behaviour' as a diagnosis.
  • Before treatment perform a structured assessment for pain, delirium, infection, hunger, thirst, constipation, urinary retention, sleep, sensory loss, environment and communication.
  • Offer psychosocial and environmental interventions first when there is no emergency, matching meaningful activity, routine, lighting, noise and carer approach to the person.
  • Antipsychotics are considered only when the person is at risk of harming themselves or others, or has agitation, hallucinations or delusions causing severe distress.
  • Use the lowest effective antipsychotic dose for the shortest possible time, reassess at least every 6 weeks and stop if there is no clear ongoing benefit.
  • People with dementia with Lewy bodies or Parkinson disease dementia can have severe antipsychotic sensitivity with rigidity, sedation, autonomic collapse or neuroleptic malignant syndrome.
  • Capacity is presumed and is specific to the decision and time; a dementia diagnosis, eccentric choice or poor memory score does not establish incapacity globally.
  • A person lacks capacity only when an impairment of mind or brain means they cannot understand, retain, use or weigh relevant information, or communicate the decision despite practicable support.
  • Best-interests decisions consider the person's wishes, values and relevant others, exclude convenience or age-based assumptions and choose the least restrictive effective option.

Key red flags

Delirium superimposed on dementia

Acute fluctuating attention, altered arousal, sleep-wake reversal or new perceptual symptoms over hours to days indicates urgent delirium assessment even with established dementia.

Lewy body sensitivity

Marked rigidity, reduced consciousness, autonomic instability or fever after an antipsychotic in Lewy body or Parkinson dementia is an emergency toxicity signal.

Undue influence or coercion

A superficially coherent decision made under pressure, fear or exploitation requires private assessment and safeguarding rather than assuming either capacity or incapacity resolves coercion.

Investigation priorities

01
Structured physical and delirium assessmentFirst step

Find acute illness, pain and physiological causes behind new behavioural change.

Management branches

Behaviour changeFind the need before choosing a drug

Distress, agitation, wandering, resistance or perceptual symptoms emerge or worsen.

  1. Define onset and behaviour precisely, assess immediate harm and perform urgent delirium, pain, retention, constipation, infection and medicine review.
  2. Ask what happens immediately before and after episodes, including staff language, personal-care task, noise, lighting, hunger and sensory access.
  3. Co-design routine, meaningful activity, communication, comfort and environmental changes with family and care staff, documenting what de-escalates distress.
  4. Measure response and reconsider diagnosis before psychotropic escalation, maintaining emergency safeguards when serious harm is imminent.

Key medicines

RisperidoneIf strictly indicated, use a low geriatric starting dose and titrate cautiously; the licensed persistent-aggression course in Alzheimer disease is limited to 6 weeks.Increased stroke and mortality risk, sedation, falls, orthostasis and extrapyramidal effects require consent and frequent review; avoid reflex use in Lewy body dementia.
HaloperidolUse only the lowest effective short-term dose within its narrow licence and local specialist protocol after ECG and interaction risks are considered.QT prolongation, torsades, rigidity, dysphagia, aspiration and neuroleptic malignant syndrome are important; severe sensitivity can occur in Lewy body and Parkinson disease dementia.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG97 dementia behaviour recommendationsStructured assessment, psychosocial care, antipsychotic thresholds and review.
  • Mental Capacity Act code of practiceStatutory principles, functional test, best interests and least restriction.
  • NICE CG103 delirium guidanceDetection and treatment of delirium superimposed on dementia.
  • MHRA antipsychotics in dementia safetyStroke, mortality and prescribing-reduction safety context.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom